Posts By :

Esperanza Mancebo

New synergies between Synchrotron ALBA and Parc Taulí
New synergies between Synchrotron ALBA and Parc Taulí 1024 768 Esperanza Mancebo
Thanks to Dr. Ibeas’ initiative (I3PT Researcher), last 3rd October the Synchrotron ALBA opened its doors to the Innovation Unit of Parc Taulí (UDIPT) guided by Dr. Ibraheem Yousef and Imma Martinez (Scientist Responsible and postdoc of the beamline BL01-MIRAS). read more

The effectiveness of Tricine as an adjuvant of cisplatin in the treatment of cutaneous squamous carcinoma is demonstrated using Synchrotron technology
The effectiveness of Tricine as an adjuvant of cisplatin in the treatment of cutaneous squamous carcinoma is demonstrated using Synchrotron technology 1024 768 Esperanza Mancebo
Dr. Silvia Gil, active member of the cancer research group of I3PT Parc Tauli, has performed in collaboration with researchers at the ALBA Synchrotron Facility a study titled “Multiparametric analysis of the cisplatin effectiveness on cutaneous squamous carcinoma cells by using two different types of adjuvants”. read more

A new method to detect patient-ventilator interactions in critically ill patients receiving mechanical ventilation
A new method to detect patient-ventilator interactions in critically ill patients receiving mechanical ventilation 1024 768 Esperanza Mancebo
In order to study the interactions between critically ill patients receiving invasive mechanical ventilation and the machine, CIBER Researchers from the Critical Care Unit of Parc Tauli in collaboration with researchers from the Althaia Foundation, IRBLleida and BetterCare developed a new non-invasive approach based on non-linear methods in order to better characterize those in a group of patient who were clinically ready to be liberated from the ventilator and in a group of patients who remove the endotracheal tube by themselves. read more